OVERSEA CHINESE BANKING Corp Ltd Buys 37,029 Shares of Danaher Corporation (NYSE:DHR)

OVERSEA CHINESE BANKING Corp Ltd lifted its stake in shares of Danaher Corporation (NYSE:DHR - Free Report) by 3,673.5% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 38,037 shares of the conglomerate's stock after purchasing an additional 37,029 shares during the quarter. OVERSEA CHINESE BANKING Corp Ltd's holdings in Danaher were worth $7,812,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. Fortis Capital Advisors LLC boosted its holdings in Danaher by 1.3% in the fourth quarter. Fortis Capital Advisors LLC now owns 3,983 shares of the conglomerate's stock valued at $914,000 after acquiring an additional 50 shares in the last quarter. Fayez Sarofim & Co boosted its holdings in Danaher by 0.6% in the fourth quarter. Fayez Sarofim & Co now owns 8,287 shares of the conglomerate's stock valued at $1,902,000 after acquiring an additional 50 shares in the last quarter. Coastal Bridge Advisors LLC boosted its holdings in Danaher by 4.8% in the fourth quarter. Coastal Bridge Advisors LLC now owns 1,099 shares of the conglomerate's stock valued at $252,000 after acquiring an additional 50 shares in the last quarter. Perennial Investment Advisors LLC boosted its holdings in Danaher by 2.2% in the fourth quarter. Perennial Investment Advisors LLC now owns 2,343 shares of the conglomerate's stock valued at $538,000 after acquiring an additional 51 shares in the last quarter. Finally, MGO One Seven LLC boosted its holdings in Danaher by 1.3% in the fourth quarter. MGO One Seven LLC now owns 4,285 shares of the conglomerate's stock valued at $984,000 after acquiring an additional 53 shares in the last quarter. 79.05% of the stock is owned by institutional investors.

Insider Buying and Selling

In other news, EVP Christopher Paul Riley sold 15,805 shares of the stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total value of $3,129,390.00. Following the transaction, the executive vice president owned 15,179 shares in the company, valued at $3,005,442. This represents a 51.01% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Chairman Steven M. Rales sold 1,250,000 shares of the stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the completion of the transaction, the chairman owned 3,105,808 shares in the company, valued at $611,036,665.92. This trade represents a 28.70% decrease in their position. The disclosure for this sale can be found here. 11.10% of the stock is owned by corporate insiders.

Danaher Stock Up 0.3%

Danaher stock traded up $0.54 during mid-day trading on Wednesday, reaching $193.40. The stock had a trading volume of 2,662,300 shares, compared to its average volume of 3,520,045. The company has a market capitalization of $138.41 billion, a price-to-earnings ratio of 37.55, a PEG ratio of 2.71 and a beta of 0.77. The company has a 50-day moving average price of $196.12 and a two-hundred day moving average price of $205.72. Danaher Corporation has a one year low of $171.00 and a one year high of $281.70. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.43 and a quick ratio of 1.05.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.62 by $0.26. The company had revenue of $5.74 billion for the quarter, compared to analysts' expectations of $5.58 billion. Danaher had a net margin of 15.81% and a return on equity of 10.80%. On average, analysts expect that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be paid a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.66%. Danaher's dividend payout ratio is presently 24.85%.

Analysts Set New Price Targets

Several analysts recently weighed in on DHR shares. The Goldman Sachs Group cut their price target on shares of Danaher from $260.00 to $240.00 and set a "neutral" rating on the stock in a report on Wednesday, April 23rd. Leerink Partners lifted their price target on shares of Danaher from $225.00 to $230.00 and gave the company an "outperform" rating in a report on Wednesday, April 23rd. Guggenheim reiterated a "buy" rating and issued a $250.00 price target on shares of Danaher in a report on Wednesday, April 23rd. JPMorgan Chase & Co. dropped their target price on shares of Danaher from $280.00 to $260.00 and set an "overweight" rating on the stock in a report on Tuesday, April 22nd. Finally, Bank of America dropped their target price on shares of Danaher from $265.00 to $230.00 in a report on Monday, April 14th. Three investment analysts have rated the stock with a hold rating and eighteen have given a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $248.43.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.